EBITDA Pipeline – Surveying EBITDA Business Owners

Investor Network by JD (A raw blog with facts and no time to cross Ts!)


We are conducting a survey with business owners of EBITDA companies. Our goal is to produce a Webinar series and other educational resources to address their major concerns. From growth to exit as well as their personal life.  Contact JD via text at +1 858-869-9483 or JD@RedHookCapital.co anytime.


Always cool to see exit image even if it is based on VC back exits!



We are focusing on almost all EBITDA companies because we provide referrals to other investors.  Today we cove some of our focused areas in specialty manufacturing and industrial technology:

  • Test & measurement
  • Flow & process control
  • Instrumentation & sensors
  • Connectivity
  • Filtration (liquids)
  • Other high value-added niche manufacturing segments Consumer Products and Services

Again, the key is a company that needs growth capital or possible consolidation play based on few high margin products for the cornerstone of the consolidation company.  I call it the cake and frosting play (i.e. high margins = frosting).

Referrals are always welcome for growth capital, consolidation, or strategy session for few hours or few days!  Text JD Morris at +1 858-869-9483


Here is a list of deals based on sales, closings, IPOs, and more!  Please always check with the website of the company or investor as this information is from the Associated Press, Bloomberg, CB Insights, Forbes, Reuters, Wall Street Journal, or other 3rd party sources.  These deals are picked because one of our advisors is an expert in the space.  Here is the Pipeline:

AC Immune SA, a Swiss biopharma company focused on developing treatments for neurodegenerative diseases associated with protein misfolding, raised $66 million in its IPO. The company priced 6 million shares at $11 per share (low end of $11-$13 range), for an initial market cap of around $609 million. It will trade on the Nasdaq under ticker symbol ACIU, while Credit Suisse, Jefferies and Leerink Partners served as underwriters. Shareholders include Dievini Hopp BioTech (37.7% pre-IPO stake). www.acimmune.com

Accruent, an Austin, Texas-based provider of real estate, facilities and asset management software, has acquired Verisae Inc., a Minneapolis-based provider of IoT cloud software that that connect facilities and assets to maintenance and service networks. No financial terms were disclosed. Accruent is a portfolio company of Genstar Capital, while Verisae had been backed by Marlin Equity Partners.www.accruent.com

Advent International is the leading bidder for Morpho, the biometric security unit of Safran SA (Paris: SAF), with an offer of around $2.7 billion, according to Bloomberg. Rival bidders include Gemalto NV and unidentified buyout firms (we are not acquiring them).

Apple (Nasdaq: AAPL) has acquired India-based machining learning startup Tuplejump for an undisclosed amount.  More via TechCrunch!

Hill-Rom (NYSE: HRC) has acquired Tridien Medical, a Coral Springs, Fla.-based maker of patient positioning and other medical devices, from Compass Diversified Holdings for an undisclosed amount. www.tridien.com


I would enjoy speaking with anyone about commercial or residential plays!  We are making a commercial map, but for residential the below works!

Accruent, provider of real estate, facilities and asset management software, has acquired Verisae Inc. continues to show that real estate is a hot space.  Residential is booming with Unicorns.  Commercial is ripe!

Contact JD Morris via text at +1 858-869-9483 to talk strategy, growth capital, or exit anytime!


Happy Networking and Investing,

JD Morris

JD Morris


Investor Network by JD

Author: JDM

Simi Private

%d bloggers like this: